PDB Short entry for 2HDH HEADER OXIDOREDUCTASE 04-DEC-98 2HDH TITLE BIOCHEMICAL CHARACTERIZATION AND STRUCTURE DETERMINATION OF HUMAN TITLE 2 HEART SHORT CHAIN L-3-HYDROXYACYL COA DEHYDROGENASE PROVIDE INSIGHT TITLE 3 INTO CATALYTIC MECHANISM COMPND MOL_ID: 1; COMPND 2 MOLECULE: L-3-HYDROXYACYL COA DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: SCHAD; COMPND 5 EC: 1.1.1.35; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: HEART; SOURCE 6 ORGANELLE: MITOCHONDRIAL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 OTHER_DETAILS: EXPRESSED AS SELENOMETHIONINE-SUBSTITUTED PROTEIN. SOURCE 10 PROTEIN WAS EXPRESSED WITH A C-TERMINAL HEXAMERIC HISTIDINE TAG. KEYWDS OXIDOREDUCTASE, BETA OXIDATION, SCHAD, CATALYTIC ACTIVITY: L-3- KEYWDS 2 HYDROXYACYL-COA + NAD(+) = 3-OXOACYL-COA + NADH EXPDTA X-RAY DIFFRACTION AUTHOR J.J.BARYCKI,J.M.BRATT,L.J.BANASZAK REVDAT 7 27-DEC-23 2HDH 1 REMARK LINK REVDAT 6 13-JUL-11 2HDH 1 VERSN REVDAT 5 24-FEB-09 2HDH 1 VERSN REVDAT 4 01-APR-03 2HDH 1 JRNL REVDAT 3 01-NOV-02 2HDH 3 HETATM REMARK REVDAT 2 27-MAR-00 2HDH 1 CRYST1 SEQADV SITE REVDAT 1 12-MAY-99 2HDH 0 JRNL AUTH J.J.BARYCKI,L.K.O'BRIEN,J.M.BRATT,R.ZHANG,R.SANISHVILI, JRNL AUTH 2 A.W.STRAUSS,L.J.BANASZAK JRNL TITL BIOCHEMICAL CHARACTERIZATION AND CRYSTAL STRUCTURE JRNL TITL 2 DETERMINATION OF HUMAN HEART SHORT CHAIN L-3-HYDROXYACYL-COA JRNL TITL 3 DEHYDROGENASE PROVIDE INSIGHTS INTO CATALYTIC MECHANISM. JRNL REF BIOCHEMISTRY V. 38 5786 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 10231530 JRNL DOI 10.1021/BI9829027 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.BIRKTOFF,H.M.HOLDEN,R.HAMLIN,N.H.XUONG,L.J.BANASZAK REMARK 1 TITL STRUCTURE OF L-3-HYDROXYACYL-COENZYME A DEHYDROGENASE: REMARK 1 TITL 2 PRELIMINARY CHAIN TRACING AT 2.8-A RESOLUTION REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 84 8262 1987 REMARK 1 REFN ISSN 0027-8424 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.3 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.4 REMARK 3 NUMBER OF REFLECTIONS : 32575 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1613 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 51.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3108 REMARK 3 BIN R VALUE (WORKING SET) : 0.3160 REMARK 3 BIN FREE R VALUE : 0.3650 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.50 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 145 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4483 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 253 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 40.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.710 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.280 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 4.870 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.640 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 8.020 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 BULK SOLVENT MODEL USED. ELECTRON DENSITY WAS NOT OBSERVED FOR THE REMARK 3 FIRST ELEVEN REMARK 3 AMINO ACIDS OF EACH SUBUNIT AND THE MAJORITY OF THE C-TERMINAL REMARK 3 HEXAMERIC HISTIDINE TAG. REMARK 4 REMARK 4 2HDH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-DEC-98. REMARK 100 THE DEPOSITION ID IS D_1000000215. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-FEB-98 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0781, 0.9794, 0.9792, 0.9355 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : APS-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34779 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.2 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 3.50000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 60.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: STATISTICS ARE FOR 1.0781 ANGSTROM DATA SET WITH BIJVOETS REMARK 200 MERGED. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M ADA, PH 6.5, 15-20% PEG 4000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.32500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.59000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.25000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 84.59000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.32500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.25000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 5350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA B 303 REMARK 465 ALA B 304 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B 302 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 73 79.74 -169.69 REMARK 500 ALA A 107 57.68 -144.58 REMARK 500 PHE A 205 -125.06 58.97 REMARK 500 ILE A 206 -66.71 -102.69 REMARK 500 ALA A 303 89.71 -61.70 REMARK 500 LYS B 16 -40.54 -133.84 REMARK 500 ASN B 73 78.21 -175.49 REMARK 500 ALA B 107 56.67 -147.17 REMARK 500 SER B 138 54.96 -114.03 REMARK 500 PHE B 205 -122.70 54.67 REMARK 500 ILE B 206 -65.05 -105.51 REMARK 500 ASP B 269 65.83 -168.07 REMARK 500 ASP B 269 65.83 -163.06 REMARK 500 ALA B 270 2.30 -57.99 REMARK 500 GLU B 287 41.33 -77.54 REMARK 500 ASN B 288 49.83 35.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AS REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ACTIVE SITE RESIDUES REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 750 REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE TO BE PUBLISHED BY O'BRIEN,SIMS,GIBSON,& STRAUSS DBREF 2HDH A 12 302 UNP Q16836 HCDH_HUMAN 24 314 DBREF 2HDH B 12 302 UNP Q16836 HCDH_HUMAN 24 314 SEQADV 2HDH ALA A 82 UNP Q16836 GLU 84 CONFLICT SEQADV 2HDH ARG A 125 UNP Q16836 PHE 137 CONFLICT SEQADV 2HDH GLN A 140 UNP Q16836 HIS 152 CONFLICT SEQADV 2HDH ALA B 82 UNP Q16836 GLU 84 CONFLICT SEQADV 2HDH ARG B 125 UNP Q16836 PHE 137 CONFLICT SEQADV 2HDH GLN B 140 UNP Q16836 HIS 152 CONFLICT SEQRES 1 A 293 LYS ILE ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY SEQRES 2 A 293 LEU MSE GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR SEQRES 3 A 293 GLY HIS THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE SEQRES 4 A 293 LEU ALA LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG SEQRES 5 A 293 LYS VAL ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA SEQRES 6 A 293 GLY ASP GLU PHE VAL ALA LYS THR LEU SER THR ILE ALA SEQRES 7 A 293 THR SER THR ASP ALA ALA SER VAL VAL HIS SER THR ASP SEQRES 8 A 293 LEU VAL VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS SEQRES 9 A 293 ASN GLU LEU PHE LYS ARG LEU ASP LYS ARG ALA ALA GLU SEQRES 10 A 293 HIS THR ILE PHE ALA SER ASN THR SER SER LEU GLN ILE SEQRES 11 A 293 THR SER ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE SEQRES 12 A 293 ALA GLY LEU HIS PHE PHE ASN PRO VAL PRO VAL MSE LYS SEQRES 13 A 293 LEU VAL GLU VAL ILE LYS THR PRO MSE THR SER GLN LYS SEQRES 14 A 293 THR PHE GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY SEQRES 15 A 293 LYS HIS PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE SEQRES 16 A 293 VAL ASN ARG LEU LEU VAL PRO TYR LEU MSE GLU ALA ILE SEQRES 17 A 293 ARG LEU TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE SEQRES 18 A 293 ASP THR ALA MSE LYS LEU GLY ALA GLY TYR PRO MSE GLY SEQRES 19 A 293 PRO PHE GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR SEQRES 20 A 293 LYS PHE ILE VAL ASP GLY TRP HIS GLU MSE ASP ALA GLU SEQRES 21 A 293 ASN PRO LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU SEQRES 22 A 293 VAL ALA GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY SEQRES 23 A 293 PHE TYR LYS TYR LYS ALA ALA SEQRES 1 B 293 LYS ILE ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY SEQRES 2 B 293 LEU MSE GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR SEQRES 3 B 293 GLY HIS THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE SEQRES 4 B 293 LEU ALA LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG SEQRES 5 B 293 LYS VAL ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA SEQRES 6 B 293 GLY ASP GLU PHE VAL ALA LYS THR LEU SER THR ILE ALA SEQRES 7 B 293 THR SER THR ASP ALA ALA SER VAL VAL HIS SER THR ASP SEQRES 8 B 293 LEU VAL VAL GLU ALA ILE VAL GLU ASN LEU LYS VAL LYS SEQRES 9 B 293 ASN GLU LEU PHE LYS ARG LEU ASP LYS ARG ALA ALA GLU SEQRES 10 B 293 HIS THR ILE PHE ALA SER ASN THR SER SER LEU GLN ILE SEQRES 11 B 293 THR SER ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE SEQRES 12 B 293 ALA GLY LEU HIS PHE PHE ASN PRO VAL PRO VAL MSE LYS SEQRES 13 B 293 LEU VAL GLU VAL ILE LYS THR PRO MSE THR SER GLN LYS SEQRES 14 B 293 THR PHE GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY SEQRES 15 B 293 LYS HIS PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE SEQRES 16 B 293 VAL ASN ARG LEU LEU VAL PRO TYR LEU MSE GLU ALA ILE SEQRES 17 B 293 ARG LEU TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE SEQRES 18 B 293 ASP THR ALA MSE LYS LEU GLY ALA GLY TYR PRO MSE GLY SEQRES 19 B 293 PRO PHE GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR SEQRES 20 B 293 LYS PHE ILE VAL ASP GLY TRP HIS GLU MSE ASP ALA GLU SEQRES 21 B 293 ASN PRO LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU SEQRES 22 B 293 VAL ALA GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY SEQRES 23 B 293 PHE TYR LYS TYR LYS ALA ALA MODRES 2HDH MSE A 26 MET SELENOMETHIONINE MODRES 2HDH MSE A 166 MET SELENOMETHIONINE MODRES 2HDH MSE A 176 MET SELENOMETHIONINE MODRES 2HDH MSE A 216 MET SELENOMETHIONINE MODRES 2HDH MSE A 236 MET SELENOMETHIONINE MODRES 2HDH MSE A 244 MET SELENOMETHIONINE MODRES 2HDH MSE A 268 MET SELENOMETHIONINE MODRES 2HDH MSE B 26 MET SELENOMETHIONINE MODRES 2HDH MSE B 166 MET SELENOMETHIONINE MODRES 2HDH MSE B 176 MET SELENOMETHIONINE MODRES 2HDH MSE B 216 MET SELENOMETHIONINE MODRES 2HDH MSE B 236 MET SELENOMETHIONINE MODRES 2HDH MSE B 244 MET SELENOMETHIONINE MODRES 2HDH MSE B 268 MET SELENOMETHIONINE HET MSE A 26 8 HET MSE A 166 8 HET MSE A 176 8 HET MSE A 216 8 HET MSE A 236 8 HET MSE A 244 8 HET MSE A 268 16 HET MSE B 26 8 HET MSE B 166 8 HET MSE B 176 8 HET MSE B 216 8 HET MSE B 236 8 HET MSE B 244 8 HET MSE B 268 16 HET NAD A 350 44 HET NAD B 750 44 HETNAM MSE SELENOMETHIONINE HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 5 HOH *253(H2 O) HELIX 1 A1 LEU A 25 ALA A 36 1 12 HELIX 2 A2 GLU A 48 LYS A 69 1 22 HELIX 3 A3 PRO A 74 SER A 86 1 13 HELIX 4 A4 ALA A 94 SER A 96 5 3 HELIX 5 A5 VAL A 98 SER A 100 5 3 HELIX 6 A6 LEU A 112 LEU A 122 1 11 HELIX 7 A7 ILE A 141 ALA A 145 1 5 HELIX 8 A8 GLN A 151 ARG A 153 5 3 HELIX 9 A9 GLN A 179 ALA A 191 1 13 HELIX 10 A10 VAL A 207 GLU A 223 1 17 HELIX 11 A11 LYS A 229 ALA A 240 1 12 HELIX 12 A12 PRO A 246 VAL A 253 1 8 HELIX 13 A14 PRO A 273 HIS A 275 5 3 HELIX 14 A15 PRO A 279 ALA A 286 1 8 HELIX 15 B1 LEU B 25 ALA B 36 1 12 HELIX 16 B2 GLU B 48 LYS B 69 1 22 HELIX 17 B3 PRO B 74 SER B 86 1 13 HELIX 18 B5 VAL B 98 SER B 100 5 3 HELIX 19 B6 LEU B 112 ASP B 123 1 12 HELIX 20 B7 THR B 142 ALA B 145 1 4 HELIX 21 B8 GLN B 151 ARG B 153 5 3 HELIX 22 B9 GLN B 179 ALA B 191 1 13 HELIX 23 B10 VAL B 207 GLU B 223 1 17 HELIX 24 B11 LYS B 229 ALA B 240 1 12 HELIX 25 B12 PRO B 246 VAL B 253 1 8 HELIX 26 B13 LEU B 255 GLU B 267 1 13 HELIX 27 B14 PRO B 273 HIS B 275 5 3 HELIX 28 B15 PRO B 279 ALA B 286 1 8 SHEET 1 A 8 HIS A 195 LYS A 200 0 SHEET 2 A 8 LEU A 168 LYS A 173 0 SHEET 3 A 8 PHE A 154 PHE A 159 -1 N HIS A 158 O GLU A 170 SHEET 4 A 8 ILE A 131 SER A 134 1 N PHE A 132 O ALA A 155 SHEET 5 A 8 LEU A 103 GLU A 106 1 N VAL A 104 O ILE A 131 SHEET 6 A 8 HIS A 17 ILE A 21 1 N THR A 19 O LEU A 103 SHEET 7 A 8 THR A 40 VAL A 44 1 N THR A 40 O VAL A 18 SHEET 8 A 8 ILE A 88 SER A 91 1 N ALA A 89 O VAL A 41 SHEET 1 B 8 HIS B 195 LYS B 200 0 SHEET 2 B 8 LEU B 168 LYS B 173 0 SHEET 3 B 8 PHE B 154 PHE B 159 -1 N HIS B 158 O GLU B 170 SHEET 4 B 8 ILE B 131 SER B 134 1 N PHE B 132 O ALA B 155 SHEET 5 B 8 LEU B 103 GLU B 106 1 N VAL B 104 O ILE B 131 SHEET 6 B 8 HIS B 17 ILE B 21 1 N THR B 19 O LEU B 103 SHEET 7 B 8 THR B 40 VAL B 44 1 N THR B 40 O VAL B 18 SHEET 8 B 8 ILE B 88 SER B 91 1 N ALA B 89 O VAL B 41 LINK C LEU A 25 N MSE A 26 1555 1555 1.33 LINK C MSE A 26 N GLY A 27 1555 1555 1.33 LINK C VAL A 165 N MSE A 166 1555 1555 1.32 LINK C MSE A 166 N LYS A 167 1555 1555 1.33 LINK C PRO A 175 N MSE A 176 1555 1555 1.33 LINK C MSE A 176 N THR A 177 1555 1555 1.33 LINK C LEU A 215 N MSE A 216 1555 1555 1.33 LINK C MSE A 216 N GLU A 217 1555 1555 1.33 LINK C ALA A 235 N MSE A 236 1555 1555 1.33 LINK C MSE A 236 N LYS A 237 1555 1555 1.33 LINK C PRO A 243 N MSE A 244 1555 1555 1.33 LINK C MSE A 244 N GLY A 245 1555 1555 1.33 LINK C GLU A 267 N AMSE A 268 1555 1555 1.33 LINK C GLU A 267 N BMSE A 268 1555 1555 1.33 LINK C AMSE A 268 N ASP A 269 1555 1555 1.33 LINK C BMSE A 268 N ASP A 269 1555 1555 1.34 LINK C LEU B 25 N MSE B 26 1555 1555 1.33 LINK C MSE B 26 N GLY B 27 1555 1555 1.33 LINK C VAL B 165 N MSE B 166 1555 1555 1.32 LINK C MSE B 166 N LYS B 167 1555 1555 1.33 LINK C PRO B 175 N MSE B 176 1555 1555 1.33 LINK C MSE B 176 N THR B 177 1555 1555 1.33 LINK C LEU B 215 N MSE B 216 1555 1555 1.33 LINK C MSE B 216 N GLU B 217 1555 1555 1.33 LINK C ALA B 235 N MSE B 236 1555 1555 1.33 LINK C MSE B 236 N LYS B 237 1555 1555 1.33 LINK C PRO B 243 N MSE B 244 1555 1555 1.33 LINK C MSE B 244 N GLY B 245 1555 1555 1.33 LINK C GLU B 267 N BMSE B 268 1555 1555 1.33 LINK C GLU B 267 N AMSE B 268 1555 1555 1.33 LINK C BMSE B 268 N ASP B 269 1555 1555 1.33 LINK C AMSE B 268 N ASP B 269 1555 1555 1.33 CISPEP 1 ASN A 161 PRO A 162 0 -0.44 CISPEP 2 ASN B 161 PRO B 162 0 -0.34 SITE 1 AS 1 GLU A 170 SITE 1 AC1 17 GLY A 24 LEU A 25 MSE A 26 ASP A 45 SITE 2 AC1 17 GLN A 46 ALA A 107 ILE A 108 GLU A 110 SITE 3 AC1 17 LYS A 115 ASN A 135 THR A 136 SER A 137 SITE 4 AC1 17 HIS A 158 PHE A 159 HOH A 802 HOH A 856 SITE 5 AC1 17 HOH A 888 SITE 1 AC2 17 ILE B 21 GLY B 24 LEU B 25 MSE B 26 SITE 2 AC2 17 ASP B 45 GLN B 46 ILE B 50 ALA B 107 SITE 3 AC2 17 ILE B 108 GLU B 110 LYS B 115 ASN B 135 SITE 4 AC2 17 THR B 136 SER B 137 HOH B 961 HOH B 990 SITE 5 AC2 17 HOH B1020 CRYST1 50.650 86.500 169.180 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019743 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011561 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005911 0.00000